Cytophenix
PrivateLast Round
Pre Seed
Oct 28, 2025
Total Funding Raised
$1.54M
Company Overview
Cytophenix is a biotechnology company developing a medical diagnostic platform for rapid antimicrobial susceptibility testing to help clinicians make timely and informed antibiotic treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytophenix Comps
Public and private peers based on sector, stage, and business model.
Cytophenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 28, 2025 | ||||
| Grant | Sep 11, 2024 | ||||
| Accelerator | Jun 5, 2024 | ||||
| Grant | May 24, 2023 |
Cytophenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| CSIRO ON Accelerate | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Grew 43% QoQ from 7 to 10 employees.
- Oct 28, 2025
$860K raised in Pre Seed round.
Cytophenix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cytophenix's valuation, stock price, and market status.
